Clinical and Laboratory Update in Thrombosis, Anticoagulation, and Vascular Medicine: A Board Review Primer

thrombosis-featureAn estimated 37 million patients are affected by thrombotic disorders each year. This number will continue to rise with the increase in our aging population. This conference focuses on clinically applicable and cutting-edge methods used in the evaluation and treatment of patients with arterial and venous thrombotic disorders.

New this year, we have expanded our course to include an overview of vascular medicine content. This additional material will provide elements useful for providers caring for patients with a broad range of vascular diseases. The format of this content will also assist physicians preparing for the American Board of Vascular Medicine (ABVM) certification/recertification examinations. Lectures and case studies will be presented by Mayo Clinic faculty with ample opportunity to ask questions and discuss difficult diagnostic or management issues. Study questions will be covered during the conference.

 

andytofilon

Andy Tofilon

Andy Tofilon is a Marketing Segment Manager at Mayo Medical Laboratories. He leads strategies for corporate communications, public relations, and new media innovations. Andy has worked at Mayo Clinic since 2003. Outside of work, Andy can be found running, hiking, snapping photos, and most importantly, spending time with his family.